The founders of Bugworks Research are attempting to bring to market a new class of antibiotics--a first in almost half a ...

Antibody-drug conjugates (ADCs), which combine monoclonal antibodies with cytotoxic agents, offer a targeted approach to cancer therapy, aiming to deliver ...

The rarity of bacterial resistance to this drug and the fact that it is not a first-line choice for i.v. treatment are added advantages. Nevertheless, we would recommend it only in cases of severe ...

except in bladder cancer, in which it likely has a H 2 O 2-dependent TS-circRNA function. Furthermore, the dysregulation of this molecule is an important mechanism for resistance to a broad spectrum ...

When I say "struggle" I mean I was close to explaining to one of the event managers that I have cancer and need to find ... I was still on a chemotherapy drug called oxaliplatin, so was wiped ...

A research team, affiliated with UNIST has unveiled an innovative technology to eliminate drug-resistant cancer cells using light. Professors Tae-Hyuk Kwon and Duyoung Min from the Department of ...

Here, we demonstrate that sustained CDK4/6i therapy, either alone or combined with CDK2i, significantly suppresses the growth of drug-resistant HR + breast cancer. Continued CDK4/6i treatment induces ...

Medicines are the main type of treatment for nearly everyone with multiple myeloma ... treatment with a bone-disease drug is usually started again. Talk with your cancer care team to learn more about ...